215 related articles for article (PubMed ID: 25657334)
1. Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors.
Kumar M; Arlauckas SP; Saksena S; Verma G; Ittyerah R; Pickup S; Popov AV; Delikatny EJ; Poptani H
Mol Cancer Ther; 2015 Apr; 14(4):899-908. PubMed ID: 25657334
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
3. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
Zimmerman T; Moneriz C; Diez A; Bautista JM; Gómez Del Pulgar T; Cebrián A; Lacal JC
Antimicrob Agents Chemother; 2013 Dec; 57(12):5878-88. PubMed ID: 24041883
[TBL] [Abstract][Full Text] [Related]
4. Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.
Mazarico JM; Sánchez-Arévalo Lobo VJ; Favicchio R; Greenhalf W; Costello E; Carrillo-de Santa Pau E; Marqués M; Lacal JC; Aboagye E; Real FX
Mol Cancer Ther; 2016 Feb; 15(2):323-33. PubMed ID: 26769123
[TBL] [Abstract][Full Text] [Related]
5. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes in glioblastomas in response to choline kinase inhibition: In vivo MRS in rodent models.
Bhaduri S; Kelly CL; Lesbats C; Sharkey J; Ressel L; Mukherjee S; Platt MD; Delikatny EJ; Poptani H
NMR Biomed; 2023 Mar; 36(3):e4855. PubMed ID: 36269130
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
[TBL] [Abstract][Full Text] [Related]
8. Preclinical study of treatment response in HCT-116 cells and xenografts with (1) H-decoupled (31) P MRS.
Darpolor MM; Kennealey PT; Le HC; Zakian KL; Ackerstaff E; Rizwan A; Chen JH; Sambol EB; Schwartz GK; Singer S; Koutcher JA
NMR Biomed; 2011 Nov; 24(9):1159-68. PubMed ID: 21994185
[TBL] [Abstract][Full Text] [Related]
9. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of novel and more effective choline kinase inhibitors against Streptococcus pneumoniae.
Zimmerman T; Chasten V; Lacal JC; Ibrahim SA
Sci Rep; 2020 Sep; 10(1):15418. PubMed ID: 32963303
[TBL] [Abstract][Full Text] [Related]
13. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
[TBL] [Abstract][Full Text] [Related]
14. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
J Natl Cancer Inst; 2004 Oct; 96(19):1457-66. PubMed ID: 15467035
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
16. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
17. The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.
Trousil S; Kaliszczak M; Schug Z; Nguyen QD; Tomasi G; Favicchio R; Brickute D; Fortt R; Twyman FJ; Carroll L; Kalusa A; Navaratnam N; Adejumo T; Carling D; Gottlieb E; Aboagye EO
Oncotarget; 2016 Jun; 7(24):37103-37120. PubMed ID: 27206796
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
Beloueche-Babari M; Arunan V; Troy H; te Poele RH; te Fong AC; Jackson LE; Payne GS; Griffiths JR; Judson IR; Workman P; Leach MO; Chung YL
Cancer Res; 2012 Feb; 72(4):990-1000. PubMed ID: 22194463
[TBL] [Abstract][Full Text] [Related]
19. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
Schiaffino-Ortega S; Baglioni E; Mariotto E; Bortolozzi R; Serrán-Aguilera L; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Hurtado-Guerrero R; Marco C; Basso G; Viola G; Entrena A; López-Cara LC
Sci Rep; 2016 Mar; 6():23793. PubMed ID: 27029499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
